Molecular profiling and clinical characteristics of Chinese patients with prostate cancer

被引：0
|
作者：
Liu, R. [1 ]
Yang, T. [2 ]
Wang, H. [2 ]
Lou, F. [2 ]
Cao, S. [2 ]
机构：
[1] Tianjin Med Univ, Hosp 2, Urol Surg, Tianjin, Peoples R China
[2] Beijing Acornmed Biotechnol Co Ltd, Dept Med, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.450
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
230P
引用
收藏
页码：S1331 / S1331
页数：1
相关论文
共 50 条
  • [31] Investigation of Optimal Prostate Biopsy Schemes for Chinese Patients with Different Clinical Characteristics
    Chen, Ming-Kun
    Luo, Yun
    Zhang, Hao
    Lu, Ming-Hua
    Pang, Jun
    Gao, Xin
    UROLOGIA INTERNATIONALIS, 2012, 89 (04) : 425 - 432
  • [32] Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer
    Sandhu, Jaspreet S.
    Vickers, Andrew J.
    Bochner, Bernard
    Donat, S. Machele
    Herr, Harry W.
    Dalbagni, Guido
    BJU INTERNATIONAL, 2006, 98 (01) : 59 - 62
  • [33] CLINICAL CHARACTERISTICS AND MOLECULAR GENETIC ANALYSIS OF A COHORT OF CHINESE PATIENTS WITH CHOROIDEREMIA
    Han, Xiaoxu
    Wu, Shijing
    Li, Hui
    Zhu, Tian
    Wei, Xing
    Zhou, Qi
    Sui, Ruifang
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (11): : 2240 - 2253
  • [34] Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency
    Lu, Deyun
    Han, Feng
    Qiu, Wenjuan
    Zhang, Huiwen
    Ye, Jun
    Liang, Lili
    Wang, Yu
    Ji, Wenjun
    Zhan, Xia
    Gu, Xuefan
    Han, Lianshu
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [35] Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency
    Deyun Lu
    Feng Han
    Wenjuan Qiu
    Huiwen Zhang
    Jun Ye
    Lili Liang
    Yu Wang
    Wenjun Ji
    Xia Zhan
    Xuefan Gu
    Lianshu Han
    Orphanet Journal of Rare Diseases, 15
  • [36] Integrative Molecular Profiling of Castration Resistant Prostate Cancer
    Sircar, K.
    Cogdell, D.
    Dhillon, J.
    Huang, H.
    Hu, L.
    Navone, N.
    Katz, R.
    Khanna, A.
    Bismar, T. A.
    Koumakpayi, I. H.
    Saad, F.
    Aprikian, A. G.
    Monzon, F. A.
    Troncoso, P.
    Zhang, W.
    LABORATORY INVESTIGATION, 2010, 90 : 220A - 220A
  • [37] Molecular profiling of prostatic fluid in prostate cancer detection
    Teng, L.
    Buck, M.
    Scells, B.
    Samaratunga, M. L. T. H.
    Yaxley, J.
    Lavin, M. F.
    Gardiner, R. A.
    BJU INTERNATIONAL, 2009, 103 : 12 - 12
  • [38] Integrative Molecular Profiling of Castration Resistant Prostate Cancer
    Sircar, K.
    Cogdeft, D.
    Dhillon, J.
    Huang, H.
    Hu, L.
    Navone, N.
    Katz, R.
    Khanna, A.
    Bismar, T. A.
    Koumakpayi, I. H.
    Saad, F.
    Aprikian, A. G.
    Monzon, F. A.
    Troncoso, P.
    Zhang, W.
    MODERN PATHOLOGY, 2010, 23 : 220A - 220A
  • [39] Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
    Rojas-Manrique, Juan P.
    Ramirez Ramirez, Angie
    Becerra Mendez, Luis Miguel
    Ramos Ulloa, Jose G.
    Riveros, Carlos
    Varela Ramirez, Rodolfo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [40] The validation of molecular profiling of circulating tumor cells from patients with advanced prostate cancer
    Fleisher, M.
    TUMOR BIOLOGY, 2006, 27
12345